KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Inventory Average (2021 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Inventory Average for 4 consecutive years, with $39.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Inventory Average rose 7.47% year-over-year to $39.0 million, compared with a TTM value of $39.0 million through Dec 2024, up 7.47%, and an annual FY2024 reading of $39.5 million, up 22.46% over the prior year.
  • Inventory Average was $39.0 million for Q4 2024 at Aurinia Pharmaceuticals, roughly flat from $38.8 million in the prior quarter.
  • Across five years, Inventory Average topped out at $39.7 million in Q1 2024 and bottomed at $16.7 million in Q2 2021.
  • Average Inventory Average over 4 years is $29.4 million, with a median of $28.2 million recorded in 2023.
  • The sharpest move saw Inventory Average skyrocketed 56.49% in 2022, then increased 7.47% in 2024.
  • Year by year, Inventory Average stood at $19.3 million in 2021, then rose by 29.66% to $25.0 million in 2022, then surged by 44.84% to $36.3 million in 2023, then grew by 7.47% to $39.0 million in 2024.
  • Business Quant data shows Inventory Average for AUPH at $39.0 million in Q4 2024, $38.8 million in Q3 2024, and $39.3 million in Q2 2024.